Simvastatin ameliorates liver fibrosis via mediating nitric oxide synthase in rats with non-alcoholic steatohepatitis-related liver fibrosis (Q35009517)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Simvastatin ameliorates liver fibrosis via mediating nitric oxide synthase in rats with non-alcoholic steatohepatitis-related liver fibrosis	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

5 August 2017

Simvastatin ameliorates liver fibrosis via mediating nitric oxide synthase in rats with non-alcoholic steatohepatitis-related liver fibrosis (English)

1 reference

Europe PubMed Central

5 August 2017

steatohepatitis

0 references

1 reference

based on heuristic

inferred from title

non-alcoholic steatohepatitis

0 references

author name string

Wei Wang

1

1 reference

Europe PubMed Central

5 August 2017

Caiyan Zhao

2

1 reference

Europe PubMed Central

5 August 2017

Junying Zhou

3

1 reference

Europe PubMed Central

5 August 2017

Zhen Zhen

4

1 reference

Europe PubMed Central

5 August 2017

Yadong Wang

5

1 reference

Europe PubMed Central

5 August 2017

Chuan Shen

6

1 reference

Europe PubMed Central

5 August 2017

language of work or name

0 references

publication date

2 October 2013

1 reference

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

5 August 2017

8

1 reference

Europe PubMed Central

5 August 2017

e76538

1 reference

Europe PubMed Central

5 August 2017

10

1 reference

Europe PubMed Central

5 August 2017

copyright license

Creative Commons Attribution 4.0 International

2 October 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Non-alcoholic fatty liver disease and the statins treatment.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788732

8 July 2018

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788732

8 July 2018

Are hepatic steatosis and carotid intima media thickness associated in obese patients with normal or slightly elevated gamma-glutamyl-transferase?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788732

8 July 2018

Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788732

8 July 2018

Pathogenesis of non-alcoholic fatty liver disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788732

8 July 2018

Impact of simvastatin on adipose tissue: pleiotropic effects in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788732

8 July 2018

Characterization of high-fat, diet-induced, non-alcoholic steatohepatitis with fibrosis in rats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788732

8 July 2018

Treatment regimens for non-alcoholic fatty liver disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788732

8 July 2018

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788732

8 July 2018

Enhanced serum concentrations of transforming growth factor-beta1 in simple fatty liver: is it really benign?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788732

8 July 2018

Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788732

8 July 2018

Bezafibrate prevents hepatic stellate cell activation and fibrogenesis in a murine steatohepatitis model, and suppresses fibrogenic response induced by transforming growth factor-beta1 in a cultured stellate cell line

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788732

8 July 2018

Endothelial nitric oxide synthase is a critical factor in experimental liver fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788732

8 July 2018

Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788732

8 July 2018

Non-alcoholic fatty liver disease: the mist gradually clears

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788732

8 July 2018

Pathogenesis and management issues for non-alcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788732

8 July 2018

PPARgamma agonists prevent TGFbeta1/Smad3-signaling in human hepatic stellate cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788732

8 July 2018

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788732

8 July 2018

Adipogenic transcriptional regulation of hepatic stellate cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788732

8 July 2018

Effect of HMG-CoA reductase inhibitors on proliferation and protein synthesis by rat hepatic stellate cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788732

8 July 2018

A pilot study using simvastatin in the treatment of nonalcoholic steatohepatitis: A randomized placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0076538

21 January 2018

Adiponectin knockout mice on high fat diet develop fibrosing steatohepatitis

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0076538

21 January 2018

Pitavastatin inhibits hepatic steatosis and fibrosis in non-alcoholic steatohepatitis model rats.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0076538

21 January 2018

Rosuvastatin ameliorates high-fat and high-cholesterol diet-induced nonalcoholic steatohepatitis in rats.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0076538

21 January 2018

Effect of simvastatin on nitric oxide synthases (eNOS, iNOS) and arginine and its derivatives (ADMA, SDMA) in ischemia/reperfusion injury in rat liver.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0076538

21 January 2018

Simvastatin enhances hepatic nitric oxide production and decreases the hepatic vascular tone in patients with cirrhosis.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0076538

21 January 2018

The vitamin E reduces liver lipoperoxidation and fibrosis in a model of nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0076538

21 January 2018

MicroRNA-34a regulates the longevity-associated protein SIRT1 in coronary artery disease: effect of statins on SIRT1 and microRNA-34a expression.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0076538

21 January 2018

Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0076538

21 January 2018

Safety and efficacy of combined ezetimibe/simvastatin treatment and simvastatin monotherapy in patients with non-alcoholic fatty liver disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788732

26 October 2018

Simvastatin inhibits cysteine-rich protein 61 expression in rheumatoid arthritis synovial fibroblasts through the regulation of sirtuin-1/FoxO3a signaling

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0076538

21 January 2018

Simvastatin treatment improves liver sinusoidal endothelial dysfunction in CCl4 cirrhotic rats

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0076538

21 January 2018

Atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-α-lowering property

1 reference

https://pubmed.ncbi.nlm.nih.gov/24098525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/24098525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

If steatosis is the atherosclerosis of the liver, are statins the "aspirin" for steatosis?

1 reference

https://pubmed.ncbi.nlm.nih.gov/24098525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence of inducible nitric oxide synthase polymorphisms in Japanese patients with non-alcoholic fatty liver disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/24098525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes: a histopathological follow-up study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24098525

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0076538

1 reference

Europe PubMed Central

5 August 2017

2013PLoSO...876538W

0 references

1 reference

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

5 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35009517&oldid=1988615751"